🔥🐔 BizChicken 🐔🔥

Companies Similar to MannKind Corporation

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Biogen Inc.

Biogen Inc. logo
Market Cap: Highest
Employees: Highest

TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, FAMPYRA, SPINRAZA, FUMADERM, BENEPALI, ADUHELM, IMRALDI, FLIXABI, RITUXAN, RITUXAN HYCELA, GAZYVA, OCREVUS

Biogen Inc. focuses on discovering, developing, manufacturing, and delivering therapies for neurological and neurodegenerative diseases, including multiple sclerosis, spinal muscular atrophy, plaque psoriasis, Alzheimer's disease, and various cancers and autoimmune conditions.

Tags: biotechnology, multiple sclerosis, neurodegenerative diseases, neurological diseases, pharmaceuticals

Symbol: BIIB

Recent Price: $150.19

Industry: Drug Manufacturers - General

CEO: Mr. Christopher A. Viehbacher

Sector: Healthcare

Employees: 7570

Address: 225 Binney Street, Cambridge, MA 02142

Phone: 617 679 2000

Leadership

  • Christopher A. Viehbacher, President and Chief Executive Officer
  • Susan H. Alexander, Chief Legal Officer
  • Ginger Gregory, Ph.D., Chief Human Resources Officer
  • Jane Grogan, Ph.D., Head of Research
  • Rachid Izzar, Head of Global Product Strategy & Commercialization
  • Adam Keeney, Head of Corporate Development
  • Michael McDonnell, Chief Financial Officer
  • Nicole Murphy, Head of Pharmaceutical Operations and Technology
  • Priya Singhal, M.D., M.P.H., Head of Development and Interim Chief Medical Officer
  • Alisha Alaimo, President, Head of North America
  • Stephen Amato, Head of Investor Relations
  • Natacha Gassenbach, Head of Corporate Affairs, Chief Communications Officer
  • Fraser Hall, President, Head of Intercontinental Region
  • Wolfram Schmidt, President, Head of Europe
  • Kendra Thomas, Head of Global Workforce Diversity, Equity & Inclusion (DE&I)
  • Caroline Dorsa, Chair of the Board
  • Maria C. Freire, Ph.D., Director
  • William A. Hawkins, Director
  • Susan Langer, Director
  • Jesus B. Mantas, Director
  • Lloyd B. Minor, M.D., Director
  • Monish Patolawala, Director
  • Eric K. Rowinsky, M.D., Director
  • Stephen A. Sherwin, M.D., Director

Last updated: 2024-12-31

Genprex, Inc.

Genprex, Inc. logo
Market Cap: Lowest
Employees: Lowest

REQORSA (GPX-001)

Genprex, Inc. is a clinical-stage gene therapy company developing therapies for cancer and diabetes, with a lead product candidate REQORSA for lung cancer treatment.

Tags: biotechnology, cancer, diabetes, gene therapy, pharmaceuticals

Symbol: GNPX

Recent Price: $0.85

Industry: Biotechnology

CEO: Mr. Ryan M. Confer M.S.

Sector: Healthcare

Employees: 21

Address: 3300 Bee Cave Road, Austin, TX 78746

Phone: 877 774 4679

Leadership

  • Amy Patel, Quality Assurance Manager
  • Celina Laney, Senior Administrative Services Manager
  • Edith Padilla, Clinical Research Associate II
  • Gina Johnson, Quality Control Manager, Stability & Product Lifecycle Management
  • Greg Jancarik, MBA, CMA, CPA, Corporate Controller
  • Jackie Opiola, Senior Clinical Project Manager
  • John Ayres, Associate Vice President & Associate General Counsel
  • Kalyn Dabbs, Senior Manager of Communications and Marketing
  • Kate Combs, Vice President of Clinical Operations
  • Laura Tirado, Senior Manager, CMC Project Management
  • Olivia Stancil, Senior Clinical Trial Assistant
  • Pier-Anne Lachance, Director of Quality Control & Product Development
  • Sarah Nguyen, Senior Manager of Quality Assurance Operations
  • Jose A. Moreno Toscano, Board Chairman
  • Ryan M. Confer, MS, President, Chief Executive Officer, Chief Financial Officer
  • Brent Longnecker, Board Director
  • William Wilson, Jr., Board Director
  • James E. Rothman, PhD, Strategic Advisor to the Board of Directors

Last updated: 2024-12-31

Lexicon Pharmaceuticals, Inc.

Lexicon Pharmaceuticals, Inc. logo
Market Cap: Medium
Employees: Low

Sotagliflozin, LX9211

Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of pharmaceutical products, with drugs like Sotagliflozin and LX9211 under development for heart failure, type 1 diabetes, and neuropathic pain.

Tags: biopharmaceutical, drug development, heart failure, neuropathic pain, type 1 diabetes

Symbol: LXRX

Recent Price: $0.72

Industry: Biotechnology

CEO: Dr. Michael Exton Ph.D.

Sector: Healthcare

Employees: 285

Address: 2445 Technology Forest Boulevard, The Woodlands, TX 77381

Phone: 281 863 3000

Leadership

  • Brian Corrigan, Senior Vice President, Regulatory and Quality Assurance
  • Brian Crum, Senior Vice President and General Counsel
  • Lisa DeFrancesco, Vice President, Investor Relations and Corporate Communications
  • Mike Exton, Ph.D., Chief Executive Officer and Director
  • Tom Garner, Senior Vice President and Chief Commercial Officer
  • Craig Granowitz, MD, PhD, Senior Vice President and Chief Medical Officer
  • Alan Main, PhD, Executive Vice President, Innovation and Chemical Sciences
  • Wendy McDermott, Senior Vice President, Human Resources
  • Kristen Alexander, Vice President, Finance and Accounting
  • Phillip Banks, MS, FRS, Vice President, Biostatistics and Data Management
  • Kyle Burt, Vice President, Information Operations
  • Amy Carroll, Ph.D., Vice President, Medical Affairs
  • Melinda Francini, Vice President, Value and Access
  • Desiree Gendron, Vice President, Sales and Training
  • Suma Gopinathan, Ph.D., Vice President, Clinical Development
  • Rachel Martens, Vice President, Partnerships and Corporate Strategy
  • Nicole Moore, Vice President, Legal
  • Tracy Newbold, Vice President, Clinical Operations
  • Godfried Owusu-Ababio, Vice President, Technical Operations
  • Rob Scala, Vice President, Business Planning and Commercial Operations
  • Carrie Siragusa, Vice President, Marketing
  • Dixon Terry, Vice President, Compliance
  • Raymond Debbane, Chairman
  • Philippe J. Amouyal,
  • Samuel L. Barker, PhD,
  • Robert J. Lefkowitz, MD,
  • Christopher J. Sobecki,
  • Diane E. Sullivan,
  • Judith L. Swain, MD,

Last updated: 2024-12-31

MannKind Corporation

MannKind Corporation logo
Market Cap: High
Employees: Medium

Afrezza

Mann Kind Corporation is a biopharmaceutical company specializing in inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin for diabetes control, and promotes Thyquidity for hypothyroidism treatment.

Tags: biopharmaceutical, diabetes, endocrine diseases, hypothyroidism, inhaled insulin, therapeutic products

Symbol: MNKD

Recent Price: $6.52

Industry: Biotechnology

CEO: Dr. Michael E. Castagna Pharm.D.

Sector: Healthcare

Employees: 411

Address: 30930 Russell Ranch Road, Westlake Village, CA 91362

Phone: 818 661 5000

Last updated: 2024-12-31

Reneo Pharmaceuticals, Inc.

Reneo Pharmaceuticals, Inc. logo
Market Cap: Lowest
Employees: Lowest

REN001

Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on developing therapies for patients with rare genetic mitochondrial diseases. Its primary product, REN001, is a selective peroxisome proliferator-activated receptor delta agonist currently in clinical trials.

Tags: Clinical Trials, Genetic Disorders, Mitochondrial Diseases, Pharmaceuticals, Therapeutics

Symbol: RPHM

Recent Price: $18.20

Industry: Biotechnology

CEO: Mr. Gregory J. Flesher

Sector: Healthcare

Employees: 8

Address: 18575 Jamboree Road, Irvine, CA 92612

Phone: 619 733 3852

Last updated: 2024-12-31

Aerovate Therapeutics, Inc.

Aerovate Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Lowest

AV-101

Aerovate Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing drugs for rare cardiopulmonary diseases, with a lead product AV-101 for pulmonary arterial hypertension.

Tags: biopharmaceutical, cardiopulmonary diseases, drug development, pulmonary arterial hypertension

Symbol: AVTE

Recent Price: $2.66

Industry: Biotechnology

CEO: Mr. Timothy P. Noyes M.B.A.

Sector: Healthcare

Employees: 51

Address: 930 Winter Street, Waltham, MA 02116

Phone: 617 443 2400

Last updated: 2024-12-31

Biomerica, Inc.

Biomerica, Inc. logo
Market Cap: Lowest
Employees: Low

diagnostic and therapeutic products

Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures, and markets diagnostic and therapeutic products for medical conditions and diseases worldwide, focusing on gastrointestinal diseases, food intolerances, and diabetes.

Tags: biomedical, diabetes, diagnostic, food intolerances, gastrointestinal, therapeutic

Symbol: BMRA

Recent Price: $0.31

Industry: Medical - Devices

CEO: Mr. Zackary S. Irani

Sector: Healthcare

Employees: 64

Address: 17571 Von Karman Avenue, Irvine, CA 92614

Phone: 949 645 2111

Last updated: 2024-12-31

Conduit Pharmaceuticals Inc.

Conduit Pharmaceuticals Inc. logo
Market Cap: Lowest
Employees: Lowest

AZD1656, AZD5904

Conduit Pharmaceuticals Inc. is a clinical stage specialty biopharmaceutical company focusing on unmet medical needs in autoimmune disease and idiopathic male infertility. Founded in 2019 and based in San Diego, California, it operates as a subsidiary of Corvus Capital Limited.

Tags: Autoimmune Disease, Biopharmaceutical, Clinical Stage, Compound Development, Idiopathic Male Infertility, Life Sciences

Symbol: CDT

Recent Price: $0.08

Industry: Biotechnology

CEO: Dr. David Joszef Tapolczay

Sector: Healthcare

Employees: 7

Address: 4995 Murphy Canyon Road, San Diego, CA 92134

Phone: 760 471 8536

Last updated: 2024-12-31

FibroGen, Inc.

FibroGen, Inc. logo
Market Cap: Lowest
Employees: Medium

Roxadustat, Pamrevlumab

Fibro Gen, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing therapeutics to treat serious unmet medical needs, including treatments for anemia, idiopathic pulmonary fibrosis, and Duchenne muscular dystrophy.

Tags: anemia, antibody, biopharmaceutical, cancer, kidney disease, pulmonary fibrosis, therapeutics

Symbol: FGEN

Recent Price: $0.53

Industry: Biotechnology

CEO: Mr. Thane Wettig

Sector: Healthcare

Employees: 486

Address: 409 Illinois Street, San Francisco, CA 94158

Phone: 415 978 1200

Last updated: 2024-12-31

Insmed Incorporated

Insmed Incorporated logo
Market Cap: Highest
Employees: Medium

ARIKAYCE, Brensocatib, Treprostinil Palmitil Inhalation Powder

Insmed Incorporated is a biopharmaceutical company founded in 1988, headquartered in Bridgewater, New Jersey. It develops and commercializes therapies for serious and rare diseases, including ARIKAYCE for Mycobacterium avium complex lung disease, Brensocatib for bronchiectasis and neutrophil-mediated diseases, and Treprostinil Palmitil Inhalation Powder for pulmonary arterial hypertension.

Tags: ARIKAYCE, Brensocatib, Treprostinil Palmitil Inhalation Powder, biopharmaceutical, rare diseases, therapies

Symbol: INSM

Recent Price: $68.87

Industry: Biotechnology

CEO: Mr. William H. Lewis J.D., M.B.A.

Sector: Healthcare

Employees: 912

Address: 700 US Highway 202/206, Bridgewater, NJ 08807

Phone: 908 977 9900

Leadership

  • William H. Lewis, J.D., M.B.A., Chair and Chief Executive Officer
  • David R. Brennan, Lead Independent Director
  • Alfred F. Altomari, Director
  • Elizabeth McKee Anderson, Director
  • Clarissa Desjardins, Ph.D., Director
  • Leo Lee, Director
  • David W.J. McGirr, Director
  • Carol A. Schafer, Director
  • Melvin Sharoky, M.D., Director

Last updated: 2024-12-31

Innoviva, Inc.

Innoviva, Inc. logo
Market Cap: Medium
Employees: Low

RELVAR/BREO ELLIPTA, ANORO ELLIPTA, TRELEGY ELLIPTA

Innoviva, Inc. engages in the development and commercialization of pharmaceuticals, focusing on respiratory therapies with its product line including RELVAR/BREO ELLIPTA, ANORO ELLIPTA, and TRELEGY ELLIPTA. The company collaborates with Sarissa Capital Management and Glaxo Group Limited.

Tags: COPD, asthma, partnerships, pharmaceuticals, respiratory therapies

Symbol: INVA

Recent Price: $17.38

Industry: Biotechnology

CEO: Mr. Pavel Raifeld C.F.A.

Sector: Healthcare

Employees: 112

Address: 1350 Old Bayshore Highway, Burlingame, CA 94010

Phone: 650 238 9600

Last updated: 2024-12-31

Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Incorporated logo
Market Cap: High
Employees: Lowest

Kyprolis, Evomela, Veklury, Teriparatide, Vaxneuvance, Pneumosil, Rylaze, Nexterone, Zulresso, Noxafil-IV

Ligand Pharmaceuticals Incorporated is a biopharmaceutical company focused on developing or acquiring technologies to aid pharmaceutical companies in discovering and developing medicines. The company's commercial programs include treatments for multiple myeloma, COVID-19, osteoporosis, invasive diseases, childhood pneumonia, and acute lymphoblastic leukemia.

Tags: biopharmaceutical, commercial programs, disease treatment, medicine development, pharmaceutical technology

Symbol: LGND

Recent Price: $105.76

Industry: Biotechnology

CEO: Mr. Todd C. Davis Ph.D.

Sector: Healthcare

Employees: 58

Address: 5980 Horton Street, EmeryVille, CA 94608

Phone: 858 550 7500

Last updated: 2024-12-31

Pulmonx Corporation

Pulmonx Corporation logo
Market Cap: Low
Employees: Low

Zephyr Endobronchial Valve

Pulmonx Corporation provides minimally invasive devices for treating chronic obstructive pulmonary diseases, including solutions like the Zephyr Endobronchial Valve and Chartis Pulmonary Assessment System.

Tags: COPD, Zephyr Valve, emphysema, healthcare, medical technology, pulmonary

Symbol: LUNG

Recent Price: $6.71

Industry: Medical - Devices

CEO: Mr. Steven S. Williamson

Sector: Healthcare

Employees: 279

Address: 700 Chesapeake Drive, Redwood City, CA 94063

Phone: 650 364 0400

Last updated: 2024-12-31

Pulmatrix, Inc.

Pulmatrix, Inc. logo
Market Cap: Lowest
Employees: Lowest

Pulmazole, PUR1800, PUR3100

Pulmatrix, Inc., a clinical stage biotechnology company, develops inhaled therapies for respiratory and other diseases with unmet medical needs, using its i SPERSE technology for drug delivery.

Tags: biotechnology, i SPERSE technology, inhaled therapies, respiratory diseases

Symbol: PULM

Recent Price: $6.86

Industry: Biotechnology

CEO: Mr. Peter Ludlum CMA, MBA

Sector: Healthcare

Employees: 22

Address: 99 Hayden Avenue, Lexington, MA 02421

Phone: 781 357 2333

Last updated: 2024-12-31

Rocket Pharmaceuticals, Inc.

Rocket Pharmaceuticals, Inc. logo
Market Cap: High
Employees: Low

Gene Therapies

Rocket Pharmaceuticals, Inc. is a biotechnology company focused on developing gene therapies for rare and devastating diseases, with multiple clinical-stage programs targeting disorders such as fanconi anemia, leukocyte adhesion deficiency-I, pyruvate kinase deficiency, and Danon disease.

Tags: Biotechnology, Clinical Stage, Gene Therapy, Healthcare, Rare Diseases

Symbol: RCKT

Recent Price: $12.03

Industry: Biotechnology

CEO: Dr. Gaurav D. Shah M.D.

Sector: Healthcare

Employees: 268

Address: 9 Cedarbrook Drive, Cranbury, NJ 08512

Phone: 609 659 8001

Last updated: 2024-12-31

ARS Pharmaceuticals, Inc.

ARS Pharmaceuticals, Inc. logo
Market Cap: High
Employees: Lowest

ARS-1, neffy

ARS Pharmaceuticals, Inc. develops ARS-1, a novel intranasal epinephrine spray and Neffy, a low-dose intranasal epinephrine nasal spray, for patients at risk of severe allergic reactions.

Tags: allergies, epinephrine, healthcare, intranasal spray, pharmaceuticals

Symbol: SPRY

Recent Price: $10.62

Industry: Biotechnology

CEO: Mr. Richard Lowenthal M.B.A., M.S., MSMSEL

Sector: Healthcare

Employees: 23

Address: 3525 Del Mar Heights Road, San Diego, CA 92130

Phone: 858 335 1300

Last updated: 2024-12-31

TFF Pharmaceuticals, Inc.

TFF Pharmaceuticals, Inc. logo
Market Cap: Lowest
Employees: Lowest

Thin Film Freezing (TFF) technology

TFF Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and commercializing drug products using its patented Thin Film Freezing technology, aimed particularly at inhaled dry powder drugs for pulmonary diseases.

Tags: TFF technology, biopharmaceutical, clinical trials, inhaled drugs, pulmonary diseases

Symbol: TFFP

Recent Price: $0.07

Industry: Biotechnology

CEO: Dr. Harlan F. Weisman

Sector: Healthcare

Employees: 19

Address: 1751 River Run, Austin, TX 76107

Phone: 817 438 6168

Last updated: 2024-12-31

Beyond Air, Inc.

Beyond Air, Inc. logo
Market Cap: Lowest
Employees: Low

Lung Fit platform

Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company, developing the Lung Fit platform, a nitric oxide generator and delivery system targeting various pulmonary conditions.

Tags: Biopharmaceutical, COVID-19, Lung Treatment, Medical Device, Nitric Oxide, Nontuberculous Mycobacteria, Persistent Pulmonary Hypertension, Viral Lung Infections

Symbol: XAIR

Recent Price: $0.38

Industry: Medical - Devices

CEO: Mr. Steven Adam Lisi

Sector: Healthcare

Employees: 107

Address: 900 Stewart Avenue, Garden City, NY 11530

Phone: 516 665 8200

Last updated: 2024-12-31

AbbVie Inc.

AbbVie Inc. logo
Market Cap: Highest
Employees: Highest

HUMIRA, SKYRIZI, RINVOQ, IMBRUVICA, VENCLEXTA, MAVYRET, CREON, Synthroid, Linzess/Constella, Lupron

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide, offering a range of therapies including HUMIRA for autoimmune diseases and MAVYRET for HCV infection.

Tags: autoimmune diseases, biotechnology, gastroenterology, healthcare, oncology, pharmaceuticals

Symbol: ABBV

Recent Price: $176.20

Industry: Drug Manufacturers - General

CEO: Mr. Robert A. Michael

Sector: Healthcare

Employees: 50000

Address: 1 North Waukegan Road, North Chicago, IL 60064-6400

Phone: 847 932 7900

Last updated: 2024-12-31

PaxMedica, Inc. Common Stock

PaxMedica, Inc. Common Stock logo
Market Cap: Lowest
Employees: Lowest

PAX-101

Pax Medica, Inc., is a clinical stage biopharmaceutical company focused on developing anti-purinergic drug therapies for treating intractable neurologic disorders. Their lead product, PAX-101, is an intravenous formulation of suramin for indications such as autism spectrum disorder and chronic fatigue syndrome.

Tags: Autism Treatment, Biopharmaceutical, Chronic Fatigue Syndrome, Drug Development, Neurologic Disorders

Symbol: PXMD

Recent Price: $0.06

Industry: Biotechnology

CEO: Mr. Howard J. Weisman

Sector: Healthcare

Employees: 6

Address: 303 South Broadway, Tarrytown, NY 10591

Phone: 914-987-2876

Last updated: 2024-12-31